Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F20%3A00008805" target="_blank" >RIV/00023884:_____/20:00008805 - isvavai.cz</a>
Result on the web
<a href="https://pubmed.ncbi.nlm.nih.gov/33272374/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/33272374/</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials
Original language description
Dr. Osmancik has received occasional speaking honoraria from Bayer and Abbott. Dr. Dukkipati has received a research grant from Biosense Webster; and owns equity in Manual Surgical Sciences and Farapulse. Dr. Reddy has received grant support from Abbott Inc. and Boston Scientific Inc.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů